 | • レポートコード：QFJ1-4161 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ドライアイ診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（蒸発性ドライアイ症候群、水性ドライアイ症候群）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ドライアイ診断＆治療の市場動向 ・企業の競争状況、市場シェア ・ドライアイ診断＆治療の種類別市場規模と予測2016-2027（蒸発性ドライアイ症候群、水性ドライアイ症候群） ・ドライアイ診断＆治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・ドライアイ診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・ドライアイ診断＆治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ドライアイ診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ドライアイ診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ドライアイ診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Allergan plc、OASIS Medical、Santen Pharmaceutical Co., Ltd.、Johnson & Johnson、Otsuka Pharmaceutical Co., Ltd.、Sentiss Pharma Pvt. Ltd.、Tomey Corporation、Carl Zeiss Meditec AG、TearLab Corporation、Bausch Health Companies, Inc.、RegeneRx (ReGenTree, LLC)） ・結論 |
Market Analysis and Insights: Global Dry Eye Disease Diagnostics and Treatment Market
The global Dry Eye Disease Diagnostics and Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dry Eye Disease Diagnostics and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dry Eye Disease Diagnostics and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dry Eye Disease Diagnostics and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dry Eye Disease Diagnostics and Treatment market.
Global Dry Eye Disease Diagnostics and Treatment Scope and Market Size
Dry Eye Disease Diagnostics and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dry Eye Disease Diagnostics and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis AG
Allergan plc
OASIS Medical
Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.
Tomey Corporation
Carl Zeiss Meditec AG
TearLab Corporation
Bausch Health Companies, Inc.
RegeneRx (ReGenTree, LLC)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Eye Disease Diagnostics and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Evaporative Dry Eye Syndrome
1.2.3 Aqueous Dry Eye Syndrome
1.3 Market by Application
1.3.1 Global Dry Eye Disease Diagnostics and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dry Eye Disease Diagnostics and Treatment Market Perspective (2016-2027)
2.2 Dry Eye Disease Diagnostics and Treatment Growth Trends by Regions
2.2.1 Dry Eye Disease Diagnostics and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dry Eye Disease Diagnostics and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dry Eye Disease Diagnostics and Treatment Industry Dynamic
2.3.1 Dry Eye Disease Diagnostics and Treatment Market Trends
2.3.2 Dry Eye Disease Diagnostics and Treatment Market Drivers
2.3.3 Dry Eye Disease Diagnostics and Treatment Market Challenges
2.3.4 Dry Eye Disease Diagnostics and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dry Eye Disease Diagnostics and Treatment Players by Revenue
3.1.1 Global Top Dry Eye Disease Diagnostics and Treatment Players by Revenue (2016-2021)
3.1.2 Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dry Eye Disease Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dry Eye Disease Diagnostics and Treatment Revenue
3.4 Global Dry Eye Disease Diagnostics and Treatment Market Concentration Ratio
3.4.1 Global Dry Eye Disease Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Eye Disease Diagnostics and Treatment Revenue in 2020
3.5 Dry Eye Disease Diagnostics and Treatment Key Players Head office and Area Served
3.6 Key Players Dry Eye Disease Diagnostics and Treatment Product Solution and Service
3.7 Date of Enter into Dry Eye Disease Diagnostics and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dry Eye Disease Diagnostics and Treatment Breakdown Data by Type
4.1 Global Dry Eye Disease Diagnostics and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Type (2022-2027)
5 Dry Eye Disease Diagnostics and Treatment Breakdown Data by Application
5.1 Global Dry Eye Disease Diagnostics and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Dry Eye Disease Diagnostics and Treatment Market Size (2016-2027)
6.2 North America Dry Eye Disease Diagnostics and Treatment Market Size by Type
6.2.1 North America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021)
6.2.2 North America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027)
6.2.3 North America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2027)
6.3 North America Dry Eye Disease Diagnostics and Treatment Market Size by Application
6.3.1 North America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021)
6.3.2 North America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027)
6.3.3 North America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2027)
6.4 North America Dry Eye Disease Diagnostics and Treatment Market Size by Country
6.4.1 North America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021)
6.4.2 North America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dry Eye Disease Diagnostics and Treatment Market Size (2016-2027)
7.2 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type
7.2.1 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2027)
7.3 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application
7.3.1 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2027)
7.4 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Country
7.4.1 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type
8.2.1 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application
8.3.1 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Region
8.4.1 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dry Eye Disease Diagnostics and Treatment Market Size (2016-2027)
9.2 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type
9.2.1 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2027)
9.3 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application
9.3.1 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2027)
9.4 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Country
9.4.1 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type
10.2.1 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application
10.3.1 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Country
10.4.1 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Dry Eye Disease Diagnostics and Treatment Introduction
11.1.4 Novartis AG Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Allergan plc
11.2.1 Allergan plc Company Details
11.2.2 Allergan plc Business Overview
11.2.3 Allergan plc Dry Eye Disease Diagnostics and Treatment Introduction
11.2.4 Allergan plc Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.2.5 Allergan plc Recent Development
11.3 OASIS Medical
11.3.1 OASIS Medical Company Details
11.3.2 OASIS Medical Business Overview
11.3.3 OASIS Medical Dry Eye Disease Diagnostics and Treatment Introduction
11.3.4 OASIS Medical Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.3.5 OASIS Medical Recent Development
11.4 Santen Pharmaceutical Co., Ltd.
11.4.1 Santen Pharmaceutical Co., Ltd. Company Details
11.4.2 Santen Pharmaceutical Co., Ltd. Business Overview
11.4.3 Santen Pharmaceutical Co., Ltd. Dry Eye Disease Diagnostics and Treatment Introduction
11.4.4 Santen Pharmaceutical Co., Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.4.5 Santen Pharmaceutical Co., Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Dry Eye Disease Diagnostics and Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Otsuka Pharmaceutical Co., Ltd.
11.6.1 Otsuka Pharmaceutical Co., Ltd. Company Details
11.6.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
11.6.3 Otsuka Pharmaceutical Co., Ltd. Dry Eye Disease Diagnostics and Treatment Introduction
11.6.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.6.5 Otsuka Pharmaceutical Co., Ltd. Recent Development
11.7 Sentiss Pharma Pvt. Ltd.
11.7.1 Sentiss Pharma Pvt. Ltd. Company Details
11.7.2 Sentiss Pharma Pvt. Ltd. Business Overview
11.7.3 Sentiss Pharma Pvt. Ltd. Dry Eye Disease Diagnostics and Treatment Introduction
11.7.4 Sentiss Pharma Pvt. Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.7.5 Sentiss Pharma Pvt. Ltd. Recent Development
11.8 Tomey Corporation
11.8.1 Tomey Corporation Company Details
11.8.2 Tomey Corporation Business Overview
11.8.3 Tomey Corporation Dry Eye Disease Diagnostics and Treatment Introduction
11.8.4 Tomey Corporation Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.8.5 Tomey Corporation Recent Development
11.9 Carl Zeiss Meditec AG
11.9.1 Carl Zeiss Meditec AG Company Details
11.9.2 Carl Zeiss Meditec AG Business Overview
11.9.3 Carl Zeiss Meditec AG Dry Eye Disease Diagnostics and Treatment Introduction
11.9.4 Carl Zeiss Meditec AG Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.9.5 Carl Zeiss Meditec AG Recent Development
11.10 TearLab Corporation
11.10.1 TearLab Corporation Company Details
11.10.2 TearLab Corporation Business Overview
11.10.3 TearLab Corporation Dry Eye Disease Diagnostics and Treatment Introduction
11.10.4 TearLab Corporation Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.10.5 TearLab Corporation Recent Development
11.11 Bausch Health Companies, Inc.
11.11.1 Bausch Health Companies, Inc. Company Details
11.11.2 Bausch Health Companies, Inc. Business Overview
11.11.3 Bausch Health Companies, Inc. Dry Eye Disease Diagnostics and Treatment Introduction
11.11.4 Bausch Health Companies, Inc. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.11.5 Bausch Health Companies, Inc. Recent Development
11.12 RegeneRx (ReGenTree, LLC)
11.12.1 RegeneRx (ReGenTree, LLC) Company Details
11.12.2 RegeneRx (ReGenTree, LLC) Business Overview
11.12.3 RegeneRx (ReGenTree, LLC) Dry Eye Disease Diagnostics and Treatment Introduction
11.12.4 RegeneRx (ReGenTree, LLC) Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
11.12.5 RegeneRx (ReGenTree, LLC) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Dry Eye Disease Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Evaporative Dry Eye Syndrome
Table 3. Key Players of Aqueous Dry Eye Syndrome
Table 4. Global Dry Eye Disease Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dry Eye Disease Diagnostics and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dry Eye Disease Diagnostics and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dry Eye Disease Diagnostics and Treatment Market Share by Regions (2016-2021)
Table 8. Global Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dry Eye Disease Diagnostics and Treatment Market Share by Regions (2022-2027)
Table 10. Dry Eye Disease Diagnostics and Treatment Market Trends
Table 11. Dry Eye Disease Diagnostics and Treatment Market Drivers
Table 12. Dry Eye Disease Diagnostics and Treatment Market Challenges
Table 13. Dry Eye Disease Diagnostics and Treatment Market Restraints
Table 14. Global Dry Eye Disease Diagnostics and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dry Eye Disease Diagnostics and Treatment Market Share by Players (2016-2021)
Table 16. Global Top Dry Eye Disease Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Disease Diagnostics and Treatment as of 2020)
Table 17. Ranking of Global Top Dry Eye Disease Diagnostics and Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dry Eye Disease Diagnostics and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dry Eye Disease Diagnostics and Treatment Product Solution and Service
Table 21. Date of Enter into Dry Eye Disease Diagnostics and Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dry Eye Disease Diagnostics and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Dry Eye Disease Diagnostics and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Dry Eye Disease Diagnostics and Treatment Product
Table 64. Novartis AG Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Allergan plc Company Details
Table 67. Allergan plc Business Overview
Table 68. Allergan plc Dry Eye Disease Diagnostics and Treatment Product
Table 69. Allergan plc Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 70. Allergan plc Recent Development
Table 71. OASIS Medical Company Details
Table 72. OASIS Medical Business Overview
Table 73. OASIS Medical Dry Eye Disease Diagnostics and Treatment Product
Table 74. OASIS Medical Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 75. OASIS Medical Recent Development
Table 76. Santen Pharmaceutical Co., Ltd. Company Details
Table 77. Santen Pharmaceutical Co., Ltd. Business Overview
Table 78. Santen Pharmaceutical Co., Ltd. Dry Eye Disease Diagnostics and Treatment Product
Table 79. Santen Pharmaceutical Co., Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 80. Santen Pharmaceutical Co., Ltd. Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Dry Eye Disease Diagnostics and Treatment Product
Table 84. Johnson & Johnson Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Otsuka Pharmaceutical Co., Ltd. Company Details
Table 87. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 88. Otsuka Pharmaceutical Co., Ltd. Dry Eye Disease Diagnostics and Treatment Product
Table 89. Otsuka Pharmaceutical Co., Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 90. Otsuka Pharmaceutical Co., Ltd. Recent Development
Table 91. Sentiss Pharma Pvt. Ltd. Company Details
Table 92. Sentiss Pharma Pvt. Ltd. Business Overview
Table 93. Sentiss Pharma Pvt. Ltd. Dry Eye Disease Diagnostics and Treatment Product
Table 94. Sentiss Pharma Pvt. Ltd. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 95. Sentiss Pharma Pvt. Ltd. Recent Development
Table 96. Tomey Corporation Company Details
Table 97. Tomey Corporation Business Overview
Table 98. Tomey Corporation Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 99. Tomey Corporation Recent Development
Table 100. Carl Zeiss Meditec AG Company Details
Table 101. Carl Zeiss Meditec AG Business Overview
Table 102. Carl Zeiss Meditec AG Dry Eye Disease Diagnostics and Treatment Product
Table 103. Carl Zeiss Meditec AG Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 104. Carl Zeiss Meditec AG Recent Development
Table 105. TearLab Corporation Company Details
Table 106. TearLab Corporation Business Overview
Table 107. TearLab Corporation Dry Eye Disease Diagnostics and Treatment Product
Table 108. TearLab Corporation Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 109. TearLab Corporation Recent Development
Table 110. Bausch Health Companies, Inc. Company Details
Table 111. Bausch Health Companies, Inc. Business Overview
Table 112. Bausch Health Companies, Inc. Dry Eye Disease Diagnostics and Treatment Product
Table 113. Bausch Health Companies, Inc. Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 114. Bausch Health Companies, Inc. Recent Development
Table 115. RegeneRx (ReGenTree, LLC) Company Details
Table 116. RegeneRx (ReGenTree, LLC) Business Overview
Table 117. RegeneRx (ReGenTree, LLC) Dry Eye Disease Diagnostics and Treatment Product
Table 118. RegeneRx (ReGenTree, LLC) Revenue in Dry Eye Disease Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 119. RegeneRx (ReGenTree, LLC) Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dry Eye Disease Diagnostics and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Evaporative Dry Eye Syndrome Features
Figure 3. Aqueous Dry Eye Syndrome Features
Figure 4. Global Dry Eye Disease Diagnostics and Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Dry Eye Disease Diagnostics and Treatment Report Years Considered
Figure 9. Global Dry Eye Disease Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dry Eye Disease Diagnostics and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dry Eye Disease Diagnostics and Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Dry Eye Disease Diagnostics and Treatment Market Share by Regions (2022-2027)
Figure 13. Global Dry Eye Disease Diagnostics and Treatment Market Share by Players in 2020
Figure 14. Global Top Dry Eye Disease Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Disease Diagnostics and Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dry Eye Disease Diagnostics and Treatment Revenue in 2020
Figure 16. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Dry Eye Disease Diagnostics and Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dry Eye Disease Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 20. North America Dry Eye Disease Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 21. North America Dry Eye Disease Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 22. United States Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dry Eye Disease Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 26. Europe Dry Eye Disease Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 27. Europe Dry Eye Disease Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 28. Germany Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dry Eye Disease Diagnostics and Treatment Market Share by Region (2016-2027)
Figure 38. China Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dry Eye Disease Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Dry Eye Disease Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Dry Eye Disease Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dry Eye Disease Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dry Eye Disease Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis AG Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 58. Allergan plc Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 59. OASIS Medical Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 60. Santen Pharmaceutical Co., Ltd. Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 62. Otsuka Pharmaceutical Co., Ltd. Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 63. Sentiss Pharma Pvt. Ltd. Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 64. Tomey Corporation Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 65. Carl Zeiss Meditec AG Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 66. TearLab Corporation Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 67. Bausch Health Companies, Inc. Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 68. RegeneRx (ReGenTree, LLC) Revenue Growth Rate in Dry Eye Disease Diagnostics and Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の非びらん性胃食道逆流症治療市場規模・現状・予測（2021年-2027年） Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). Market Analysis and Insights: Global Nonerosive Reflux Disease Treatment Market The global Nonerosi…- 世界のスティル病治療市場規模・現状・予測（2021年-2027年） Still’s disease is a rare rheumatic condition. This condition is characterized by biological and clinical symptoms such as high spiking fever, joint swelling, muscle pain, sore throat, increased number of white cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for still…
- 世界の咳過敏症症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cough Hypersensitivity Syndrome Treatment Market The global Cough Hypersensitivity Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
- 世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
- 世界のデント病治療市場規模・現状・予測（2021年-2027年） Dent disease treatment offers treatment to rare genetic kidney disorder. To reduce the quantity of calcium in the urine and to decrease the recurrent occurrence of nephrolithiasis, dent disease treatment plays an important role. Additionally, dent disease treatment cures the kidney calcifications wh…